Search Results 1321-1330 of 23644 for Intestine

  1. 3D Anatomic Modeling Laboratories - Overview - Mayo Clinic

    Do they share intestines? So one of the surgeons said, Can we make a physical copy of their liver? And they said, Well, why don't we 3D print it? So the ...

  2. Vascular centers - Doctors - Mayo Clinic

    ... Intestinal ischemia, Arteriovenous fistula, Fibromuscular dysplasia, Renal artery stenosis, Venous disorder, Thoracic aortic aneurysm, Arteriosclerosis ...

  3. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

    ... intestinal absorption). Concurrent or previous other malignancy within 5 years of study entry, except cured basal or squamous cell skin cancer, superficial ...

  4. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Intestinal obstruction, Achalasia, Fecal incontinence, Solitary rectal ulcer syndrome, Hiatal hernia, Pediatric trauma, Familial adenomatous polyposis ...

  5. Polyethylene glycol 3350, sodium and potassium salts (oral route) - Side effects & dosage - Mayo Clinic

    Toxic megacolon (very dilated or swollen intestine)—Should not be used in patients with these conditions. Back to top. Proper Use. Your doctor may have ...

  6. Medical Research & Education - Mayo Clinic News Network

    Study Suggests G9a Enzyme May Inhibit Intestinal Inflammation featured image. Research. Study Suggests G9a Enzyme May Inhibit Intestinal Inflammation. Gerri ...

  7. Gastrointestinal-bladder fistula (an unusual link between the intestines and the bladder); Kidney infection — which can affect one or both kidneys. Kidney ...

  8. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    Prior history of clinically significant bleeding, intestinal obstruction, or GI perforation within 6 months of randomization. Infection requiring antibiotic ...

  9. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    Gastrointestinal disease (e.g., gastric or intestinal bypass surgery, pancreatic enzyme insufficiency, malabsorption syndrome, symptomatic inflammatory ...

  10. Paroxetine (oral route) - Side effects & dosage - Mayo Clinic

    If you take them together or do not wait 2 weeks, you may develop confusion, agitation, restlessness, stomach or intestinal symptoms, a sudden high body ...